Cannabidiol and epilepsy
31 October 2020, 20:00 - 22:00 Greenwich Mean Time
ILAE Curriculum Learning Objectives addressed by this course
- 3.1.2 Demonstrate knowledge of pharmacokinetics and pharmacodynamics (L1)
- 3.1.3 Demonstrate knowledge regarding the adverse effects of antiepileptic drugs (L1)
- 3.1.5 Demonstrate knowledge about drug interactions (e.g. enzyme induction, etc.) for AED/AED and AED/concomitant medication
- 3.2.1 Recommend appropriate therapy according to seizure type (L1)
- 3.2.2 Recommend appropriate therapy according to epilepsy syndrome (L2)
- 3.2.3 Recommend individualized titrations of optimal dosing for patients including starting and discontinuing medication (L1)
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community